Literature DB >> 21120209

Image analytic study of nuclear area in mantle cell lymphoma.

Taehwa Baek1, Jooryung Huh, Hyoungjong Kwak, Meeja Park, Hyekyung Lee.   

Abstract

BACKGROUND: Malignant lymphomas are classified on the basis of morphology, immunohistochemistry, and genetic and molecular biological features. Morphology is considered the most important and basic feature. Lymphomas can be classified as small, medium, or large depending on the cell size, but this criterion tends to be rather subjective. The aim of this study was to investigate the usefulness of an objective approach based on quantitative measurements.
METHODS: Twenty specimens of mantle cell lymphoma and 2 specimens of the tonsil were examined. The nuclear area of 6,401 tumor cells of mantle cell lymphoma and 743 normal mantle cells of reactive tonsils were measured by 3 authors by using a user-controlled image-analyzer. The images of the nuclei were outlined using the spline method and the i-solution software, and the data were assessed using ANOVA and Student's t-test.
RESULTS: The mean nuclear areas of mantle cell lymphoma cells measured by the 3 authors were 37.9 [7.9] µm(2), 37.9 [7.2] µm(2), and 38.2 [7.7] µm(2) and those of normal mantle cells in reactive tonsil were 28.6 [2.3] µm(2), 28.8 [2.0] µm(2), and 27.0 [3.0] µm(2). There was no statistical difference between the 3 observations of mantle cell lymphoma (P=0.580) and normal tonsils.
CONCLUSION: For morphology, nuclear area is considered an important feature in the classification schemes of lymphoma. We showed that nuclear area measurement by using image analyzer can be used as an objective quantitative method. We think that nuclear morphometry may play a significant role in the diagnosis of lymphoma.

Entities:  

Keywords:  Image analysis; Mantle cell lymphoma; Morphometry; Nuclear area

Year:  2010        PMID: 21120209      PMCID: PMC2983036          DOI: 10.5045/kjh.2010.45.3.193

Source DB:  PubMed          Journal:  Korean J Hematol        ISSN: 1738-7949


  11 in total

1.  Standardization of nuclear morphometry-based biomarkers.

Authors:  Rochelle P Ondracek; Felicia Parker; April Allen; Warren Davis; Michael Ray; William McCann; James R Marshall
Journal:  Anal Quant Cytol Histol       Date:  2007-10       Impact factor: 0.302

2.  A study of nuclear diameters in lymph node imprints using the Zeiss Microvideomat.

Authors:  J Crocker; R C Curran
Journal:  J Clin Pathol       Date:  1979-07       Impact factor: 3.411

Review 3.  Morphometric and related quantitative techniques in the study of lymphoid neoplasms. A review.

Authors:  J Crocker
Journal:  J Pathol       Date:  1984-06       Impact factor: 7.996

4.  Study of nuclear sizes in the centres of malignant and benign lymphoid follicles.

Authors:  J Crocker; E L Jones; R C Curran
Journal:  J Clin Pathol       Date:  1983-12       Impact factor: 3.411

5.  Morphometric characterisation of 52 B cell non-Hodgkin's lymphomas.

Authors:  P van der Valk; A Mosch; P J Kurver; C J Meijer
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

6.  Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma.

Authors:  D D Weisenburger; H Kim; H Rappaport
Journal:  Cancer       Date:  1982-04-01       Impact factor: 6.860

7.  Study of nuclear diameters in non-Hodgkin's lymphomas.

Authors:  J Crocker; E L Jones; R C Curran
Journal:  J Clin Pathol       Date:  1982-09       Impact factor: 3.411

8.  Diagnostic value of combining immunostaining for CD3 and nuclear morphometry in mycosis fungoides.

Authors:  M Lira; A A Schenka; L A Magna; A C Cotta; M L Cintra; E M de Souza; P Brousset; J Vassallo
Journal:  J Clin Pathol       Date:  2007-05-11       Impact factor: 3.411

Review 9.  Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.

Authors:  Elaine S Jaffe; Nancy Lee Harris; Harald Stein; Peter G Isaacson
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

10.  Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases.

Authors:  D D Weisenburger; B N Nathwani; L W Diamond; C D Winberg; H Rappaport
Journal:  Cancer       Date:  1981-09-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.